1. Fragment-based discovery of orphan nuclear receptor Nur77/NGFI-B ligands
- Author
-
Silvia Arifi, Daniel Zaienne, Jan Heering, Thomas Wein, Rezart Zhubi, Apirat Chaikuad, Stefan Knapp, Julian A. Marschner, Daniel Merk, and Publica
- Subjects
Virtual screening ,Receptors, Steroid ,Organic Chemistry ,Apoptosis ,NR4A ,Ligands ,Orphan Nuclear Receptors ,Biochemistry ,Neoplasms ,Drug Discovery ,Nuclear Receptor Subfamily 4, Group A, Member 1 ,Humans ,Neurodegeneration ,Transcription factor ,Molecular Biology ,Cancer - Abstract
The transcription factor nerve growth factor-induced clone B (NGFI-B, Nur77, NR4A1) is an orphan nuclear receptor playing a role in cell survival and apoptosis regulation. Pharmacological Nur77 modulation holds promise for cancer and (neuro-)inflammatory disease treatment. The available Nur77 ligand scaffolds based on highly lipophilic natural products cytosporone B, celastrol and isoalantolactone are inadequate for the development of potent Nur77 modulators with favorable properties as chemical tools and future drugs. By fragment library screening and subsequent modeling for fragment extension, we have obtained a set of new Nur77 ligands offering alternative chemotypes for the development of Nur77 agonists and inverse agonists. Computer-aided fragment extension in a second stage screening yielded a Nur77 agonist with significant activation efficacy and preference over the related NR4A receptors.
- Published
- 2022